Preview Mode Links will not work in preview mode

The AI in Business Podcast is for non-technical business leaders who need to find AI opportunities, align AI capabilities with strategy, and deliver ROI.

Each week, Emerj Artificial Intelligence Research CEO Daniel Faggella interviews top AI executives from Fortune 500 firms and unicorn startups - to uncover trends, use-cases, and best practices for practical AI adoption.

Subscribe to Emerj's weekly AI newsletter by downloading our "Beginning with AI" PDF guide

Apr 17, 2024

Today’s guests are Arkestro Founder & Chief Strategy Officer Edmund Zagorin and Johnson & Johnson Chief Procurement Officer Len DeCandia. Arkestro is an AI-driven startup in the procurement space with broad partnerships across the automotive, construction, and manufacturing sectors, including Johnson & Johnson and...


Apr 16, 2024

Today’s guest is Chris Helsel, Senior Vice President of Global Operations and Chief Technology Officer at The Goodyear Tire & Rubber Company. Despite the disparity in the predictions about self-driving cars that were made a decade ago, the era of automated transportation is close at hand. Chris joins the podcast today...


Apr 14, 2024

Today’s guest is Dr. John Almasan, Head of AI & Emerging Technologies at TIAA. TIAA, or the Teachers Insurance and Annuity Association of America-College Retirement Equities Fund, is a US-based insurance provider specializing in retirement services in areas like academia, research, healthcare, and government....


Apr 9, 2024

Today’s guest is Shreyas Becker, Head of AI & Data Products, Manufacturing & Supply at Sanofi. Shreyas joins Emerj Senior Editor Matthew DeMello on today’s podcast to talk about alleviating pain points for supply chain leaders in life sciences spaces. From building systems that deliver “real world evidence” to...


Apr 3, 2024

Today’s guest is Daniel Ferrante, AI Leader in R&D and Data Strategy at Deloitte. Together with Emerj CEO and Head of Research Daniel Faggella, they delve into the complex challenges in AI adoption that major pharmaceutical firms encounter with cultural shifts, technological complexities, and the difficulties...